Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $144.7M | $117.3M |
| COGS | $0 | $0 |
| Gross Profit | — | — |
| R&D | $0 | $0 |
| SG&A | $24.5M | $26.6M |
| Selling And Marketing Expense | $6.3M | $9.2M |
| General And Administrative Expense |
QuarterCharts · SEC EDGAR data · HIPO · Comparing FY2026 (Q2) vs FY2025 (Q2)
| $18.2M |
| $17.4M |
| D&A | $0 | $0 |
| Other OpEx | $0 | $0 |
| Operating Income | — | — |
| Interest Exp. | $0 | $400K |
| Other Non-Op | — | — |
| Non-Op Income | — | — |
| Costs not shown separately | $109.2M | $86.3M |
| Pretax Income | $11M | $4M |
| Tax | $900K | $100K |
| Other (Below Tax) | $0 | $0 |
| Other Income (After Tax) | $0 | $0 |
| Tax Benefit | $0 | $0 |
| Net Income Consolidated | — | $3.9M |
| Noncontrolling Interest | — | $2.6M |
| Net Income | $10.1M | $1.3M |
